Literature DB >> 8719809

Attenuation by creatine of myocardial metabolic stress in Brattleboro rats caused by chronic inhibition of nitric oxide synthase.

D Constantin-Teodosiu1, P L Greenhaff, S M Gardiner, M D Randall, J E March, T Bennett.   

Abstract

1. The present experiment was undertaken to investigate: (a) the effect of nitric oxide synthase (NOS) inhibition, mediated by oral supplementation of the NOS inhibitor, NG-nitro-L-arginine methyl ester (L-NAME), on measures of myocardial energy metabolism and function: (b) the effect of oral creatine supplementation on these variables, in the absence and presence of L-NAME. 2. In one series of experiments, 4 weeks oral administration of L-NAME (0.05 mg ml-1 day-1 in the drinking water) to Brattleboro rats caused significant reductions in myocardial ATP, creatine, and total creatine concentrations and an accumulation of tissue lactate when compared with control animals. Administration of creatine (0.63 mg ml-1 day-1 in the drinking water) for 4 weeks elevated myocardial creatine and total creatine concentrations and reduced lactate accumulation, but did not significantly affect ATP or phosphocreatine (PCr). Concurrent treatment with creatine and L-NAME prevented the reduction in creatine and total creatine concentrations, and significantly attenuated the accumulation of lactate and the reduction in ATP seen with L-NAME alone. 3. In a second series of experiments, 4 weeks treatment with L-NAME and creatine plus L-NAME increased mean arterial blood pressure in conscious Brattleboro rats. Hearts isolated from these animals showed decreased coronary flow and left ventricular developed pressure (LVDP), and total mechanical performance. Treatment with creatine alone had no measurable effect on either mean arterial blood pressure or coronary flow in isolated hearts. However, there was an increase in LVDP, but not in total mechanical performance, because there was a bradycardia. 4. These results indicate that creatine supplementation can attenuate the metabolic stress associated with L-NAME administration and that this effect occurs as a consequence of the action of creatine on myocardial energy metabolism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8719809      PMCID: PMC1909156          DOI: 10.1111/j.1476-5381.1995.tb15137.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Skeletal muscle function and structure after depletion of creatine.

Authors:  R P Shields; C K Whitehair; R E Carrow; W W Heusner; W D Van Huss
Journal:  Lab Invest       Date:  1975-08       Impact factor: 5.662

2.  Glycogen, glycolytic intermediates and high-energy phosphates determined in biopsy samples of musculus quadriceps femoris of man at rest. Methods and variance of values.

Authors:  R C Harris; E Hultman; L O Nordesjö
Journal:  Scand J Clin Lab Invest       Date:  1974-04       Impact factor: 1.713

3.  Creatine kinase kinetics, ATP turnover, and cardiac performance in hearts depleted of creatine with the substrate analogue beta-guanidinopropionic acid.

Authors:  E A Shoubridge; F M Jeffry; J M Keogh; G K Radda; A M Seymour
Journal:  Biochim Biophys Acta       Date:  1985-10-30

Review 4.  A simple analysis of the "phosphocreatine shuttle".

Authors:  R A Meyer; H L Sweeney; M J Kushmerick
Journal:  Am J Physiol       Date:  1984-05

5.  Regional haemodynamic changes during oral ingestion of NG-monomethyl-L-arginine or NG-nitro-L-arginine methyl ester in conscious Brattleboro rats.

Authors:  S M Gardiner; A M Compton; T Bennett; R M Palmer; S Moncada
Journal:  Br J Pharmacol       Date:  1990-09       Impact factor: 8.739

6.  Biochemical and ultrastructural changes in skeletal muscle induced by a creatine antagonist.

Authors:  M B Laskowski; R Chevli; C D Fitch
Journal:  Metabolism       Date:  1981-11       Impact factor: 8.694

7.  The creatine kinase system in normal and diseased human myocardium.

Authors:  J S Ingwall; M F Kramer; M A Fifer; B H Lorell; R Shemin; W Grossman; P D Allen
Journal:  N Engl J Med       Date:  1985-10-24       Impact factor: 91.245

8.  A 31P-nuclear magnetic resonance study of skeletal muscle metabolism in rats depleted of creatine with the analogue beta-guanidinopropionic acid.

Authors:  E A Shoubridge; G K Radda
Journal:  Biochim Biophys Acta       Date:  1984-09-14

9.  Left ventricular hypertrophy and risk of cardiac failure: insights from the Framingham Study.

Authors:  W B Kannel; D Levy; L A Cupples
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

10.  Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation of the rabbit.

Authors:  J L Amezcua; R M Palmer; B M de Souza; S Moncada
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

View more
  3 in total

Review 1.  Creatine and the creatine transporter: a review.

Authors:  R J Snow; R M Murphy
Journal:  Mol Cell Biochem       Date:  2001-08       Impact factor: 3.396

2.  Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease.

Authors:  R T Matthews; L Yang; B G Jenkins; R J Ferrante; B R Rosen; R Kaddurah-Daouk; M F Beal
Journal:  J Neurosci       Date:  1998-01-01       Impact factor: 6.167

3.  Effect of a rosmarinic acid supplemented hemodialysis fluid on inflammation of human vascular endothelial cells.

Authors:  W-J Wang; M-H Cheng; J-H Lin; C-S Weng
Journal:  Braz J Med Biol Res       Date:  2017-10-19       Impact factor: 2.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.